Juven® | Podiatry Case Studies

“Two months after the amputation of two toes in July, the patient’s left foot wound hadn’t healed. In December, a failed amputation flap occurred; and on February 28 of the following year, the patient began a 30-day trial of Juven.*

With no other change to his care but the addition of Juven, the wound began to heal and continued healing after his supply of Juven was used up.”

Before Juven

Juven Day 19

17 Days Post 30 Day Juven Trial

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

“I was treating a diabetic patient with a plantar heel ulcer. While revascularization, local wound care with collagen dressings, and offloading had improved the ulcer to a degree, progress was minimal and slow. At that point, we added a twice-daily regimen of Juven.* Within about two weeks, there was noticeable improvement.

By her most recent visit, the ulcer has reduced in size significantly, and has nearly closed over the space of six weeks. No other changes in her treatment regimen had been initiated, so I attribute much of the acceleration of the healing process to the Juven.”

At baseline, the wound measured 2.3 cm long, 1.5 cm wide, and 2 mm deep. This female patient fell within the age range of 70+. The healthcare professional in charge was a doctor of podiatric medicine.

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

“I placed my patient on a Juven* trial as he is at high risk of proximal foot amputation due to previous infection treated by distal amputation. There was soft tissue loss, and my patient had undergone a bioengineered graft placement with subsequent failure of the graft.

At this point, Juven was started in an attempt to increase healing potential. He has done fantastic with its use. I will continue to have my patient take Juven during the duration of his treatment and will continue to recommend it for patients with ulcers.”

At baseline, the wound measured 6.7 cm long, 2.5 cm wide, and 0.5 cm deep. This male patient fell within the age range of 56-70. The healthcare professional in charge was a doctor of podiatric medicine.

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

“As a type 2 diabetic for over 30 years. I have trouble healing from foot wounds due to neuropathy. This latest lesion was healing very slowly, so Juven seemed like a good addition to my wound care. The Juven* seems to have been effective in finally getting the 12-week old lesion to heal! Now I am on a path to recovery!”

This male patient fell within the age range of 70+. The healthcare professional in charge was a registered dietitian.

Baseline

Juven Day 19

Juven Day 35

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

“My patient had not healed her toe ulcer for a year, and she started losing weight intentionally. I wanted to make sure she had the proper nutrition for healing – so I recommended Juven*. Within one month of using Juven the patient’s wound healed. Both the patient and I are very happy!”

At baseline, the wound measured 0.4 cm long, 0.4 cm wide, and 0.2 cm deep. This female patient fell within the age range of 56-70. The healthcare professional in charge was a doctor of podiatric medicine.

Baseline

Juven Day 21

Juven Day 35

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

A 62-year-old male had a 20-year history of diabetes mellitus when he developed a diabetic foot ulcer with osteomyelitis. The patient sought medical attention after a crack on the bottom of his foot developed into a lesion. The tissue around the lesion was inflamed and necrotic. Four weeks later, the wound team administered a debriding treatment. The ulcer worsened and the patient developed osteomyelitis. The patient was treated with IV antibiotics for the next 9 months.

August—Before Juven therapy

Wound team decided that the ulcer required a second debridement. After the procedure, wound measured 6.35 cm (L) x 5.08 cm (W) x 2.54 cm (H).

Physician directed patient to clean the wound, change the dressing daily, and take an oral antibiotic (levofloxacin).
In spite of the debridement, good home care, and adequate nutrition, the wound continued to worsen.
Consulting physician recommended below-the-knee amputation and wound team recommended hyperbaric oxygen therapy.

October—After 2 weeks of Juven therapy

Faced with potential amputation and hyperbaric oxygen therapy, the physician suggested that the patient add 2 packets of Juven to his daily diet.

Patient mixed 1 packet of Juven with 8-10 fl oz of water, twice a day.
After 2 weeks, patient noticed his wound beginning to heal.
Patient continued to take Juven every morning and night for 6 weeks.

December—After 14 weeks of Juven therapy

Wound had reached remodeling phase.

Patient returned to the wound care center for a follow-up visit.
Ulcer surface had diminished to 3.81 cm (L) x 1.27 cm (W).

At baseline, the wound measured 6.35 cm long, 5.08 cm wide, and 2.54 cm deep. This male patient fell within the age range of 56-70.

Juven was used in addition to a standard wound care program. Results may vary depending on the type and severity of the wound.

Healthcare Professionals

Failed Amputation Flap, Left Foot

Plantar Ulcer, Heel

DM Ulcer, Left Foot

Diabetic Foot Ulcer

Diabetic Foot Ulcer, Toe

Diabetic Foot Ulcer With Osteomyelitis

How Juven Works

Case Studies

SITE PAGES

ABBOTT

ABBOTT BRANDS

Healthcare Professionals

Failed Amputation Flap, Left Foot

Plantar Ulcer, Heel

DM Ulcer, Left Foot

Diabetic Foot Ulcer

Diabetic Foot Ulcer, Toe

Diabetic Foot Ulcer With Osteomyelitis

How Juven Works

Case Studies

SITE PAGES

ABBOTT

ABBOTT BRANDS

STAY CONNECTED